Yes... very true and I am just trying to dig deeper and out of the box to find out what other possibilities could have been set up at that time.
For one, I think Ben Kramer-Miller is part of it but like I said before... I check every single path and some lead no where and some surprisingly, connect in some way.
I don't believe Ben Kramer-Miller mentioned Peregrine Pharmaceuticals in his article for no reason at all and if XON is the stock to own for the next decade and if some with XON P53 etc knows that PS Targeting is required, maybe Ben Kramer-Miller should dig deeper and he may think that if XON is the stock to own for the next decade, then Peregrine Pharmaceuticals would be the stock to own for the next two decades or at minimum until PS Targeting patents begin to expire. Of course, by that time.... Peregrine and PS Targeting revenues will bring in much money in order to diversify in all directions outside of the traditional Big Pharma like business.
Ben Kramer-Miller Articles ... a reminder to all for the patent filing date and publication date:
Time to connect some dots with Peregrine employees/KOL's , Sunil Chada and finance guys and BP affiliations and much more... unfortunately, I need to head back to California for the 2nd time in like 5 or 6 years and the posts will be short and sweet but getting closer.